Athira Pharma, a US-based clinical-stage company developing innovative first-in-class regenerative therapies with the potential to restore brain function, announced the closing of a $85 million Series B financing led by Perceptive Advisors. Other investors that took part in the funding round include RTW Investments, Viking Global Investors, Venrock Healthcare Capital Partners, Franklin Templeton, Rock Springs…